José Euzébio Gonçalves Junior
Research Subjects
José Euzébio Gonçalves Junior has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Beatriz Sant’aNna
Vichy Laboratoires , Levallois-Perret
2 shared publications - Delphine Kerob
La Roche-Posay Laboratoire Dermatologique, L'Oreal Dermatological Beauty Division, Levallois, France
2 shared publications - Priscila Correia
Scientific Expertise, L’Oréal Brazil, Rio de Janeiro, Brazil
2 shared publications - Bruna Souza Felix Bravo
Private Clinic, Rio de Janeiro, Brazil
1 shared publication - Jean Krutmann
Environmentally-Induced Skin Aging Group, IUF-Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany; Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
1 shared publication - Juliane Rocio Neves
Dermatology Department of HFAG Rio de Janeiro Brazil
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 21 October 2022
- Published by Wiley in Dermatologic Therapy
- Vol. 35 (12)
Benefits of topical hyaluronic acid for skin quality and signs of skin aging: From literature review to clinical evidence
Skin aging goes beyond a chronological process and also results from extrinsic factors referred to as the exposome. Hyaluronic acid (HA) is an important component of the extracellular matrix, with loss starting at 25 years old. While many studies of HA concern topical use, few literature reviews only address the use of topical HA in dermatology. This review describes the different characteristics of HA‐containing cosmeceuticals, with a focus on skin aging and the impact of exposome factors on HA synthesis and degradation. A review was performed using the terms HA, hyaluronan, topical, dermatology, cosmetic, aging treatment, exposome, and cosmeceuticals. Results are also presented from a recent randomized controlled trial (RCT), which investigated the additional benefit of using a HA epidermic filler (HA‐filler serum) combined with Botulinum toxin type A (BoNTA) to treat signs of skin aging. Subjects were randomized to two groups: HA‐filler serum starting 24 h after the BoNTA injection then twice daily for 24 weeks, or the control group, which received BoNTA. HA is a key ingredient used in cosmeceuticals for its hydration/antiaging properties (hygroscopic, rheological, and viscoelastic). Several clinical studies indicate that HA is both well tolerated and effective, adjuvant to both post‐surgical and facial rejuvenation procedures. In the RCT, one of few studies to combine BoNTA and HA with a 6‐month follow‐up, the HA‐filler serum lengthened the duration of BoNTA's effect in reducing wrinkles. Numerous studies support HA‐based cosmeceuticals as a noninvasive, effective solution for improving skin hydration and rejuvenation.
- 21 October 2022
- Published by Wiley in Dermatologic Therapy
- Vol. 35 (12)
Top Cited PapersOpen AccessBenefits of topical hyaluronic acid for skin quality and signs of skin aging: From literature review to clinical evidence
Skin aging goes beyond a chronological process and also results from extrinsic factors referred to as the exposome. Hyaluronic acid (HA) is an important component of the extracellular matrix, with loss starting at 25 years old. While many studies of HA concern topical use, few literature reviews only address the use of topical HA in dermatology. This review describes the different characteristics of HA‐containing cosmeceuticals, with a focus on skin aging and the impact of exposome factors on HA synthesis and degradation. A review was performed using the terms HA, hyaluronan, topical, dermatology, cosmetic, aging treatment, exposome, and cosmeceuticals. Results are also presented from a recent randomized controlled trial (RCT), which investigated the additional benefit of using a HA epidermic filler (HA‐filler serum) combined with Botulinum toxin type A (BoNTA) to treat signs of skin aging. Subjects were randomized to two groups: HA‐filler serum starting 24 h after the BoNTA injection then twice daily for 24 weeks, or the control group, which received BoNTA. HA is a key ingredient used in cosmeceuticals for its hydration/antiaging properties (hygroscopic, rheological, and viscoelastic). Several clinical studies indicate that HA is both well tolerated and effective, adjuvant to both post‐surgical and facial rejuvenation procedures. In the RCT, one of few studies to combine BoNTA and HA with a 6‐month follow‐up, the HA‐filler serum lengthened the duration of BoNTA's effect in reducing wrinkles. Numerous studies support HA‐based cosmeceuticals as a noninvasive, effective solution for improving skin hydration and rejuvenation.
- 12 February 2022
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 21 (10) , 4462-4469
Efficacy of a topical serum containing L‐ascorbic acid, neohesperidin, pycnogenol, tocopherol, and hyaluronic acid in relation to skin aging signs
Background: Skin aging is a process regulated by chronological aging and amplified by exposome factors including chronic UV exposure and pollution, which both induce reactive oxygen species. Topical antioxidants have the potential to counteract this process and to improve skin aging signs, including wrinkles and hyperpigmentation.Objective: To evaluate the efficacy of a topical antioxidant serum containing 15% L‐ascorbic acid, neohesperidin, Pinus pinaster bark, tocopherol, and hyaluronic acid (HA) ex vivo on air pollution‐induced pigmentation and gene expression, as well as in vivo on skin aging signs in Brazilian volunteers, after 90 days of use.Methods: Ex vivo human skin samples were repetitively exposed to Diesel Exhaust Particles (DEP) and subsequently analyzed for changes in pigmentation and gene expression. Clinical efficacy was evaluated in 40 healthy adult females with phototype II to IV and visible photoaging signs, including facial hyperpigmentation, through dermatological evaluation and instrumental analysis including Reflectance Confocal Microscopy.Results: Ex vivo, the topical antioxidant serum significantly reduced DEP‐induced skin pigmentation and expression of proinflammatory genes. A significant improvement of skin aging signs was observed after 90 days. Local tolerance was good.Conclusion: The tested serum is effective in protecting human skin ex vivo against air pollution‐induced skin pigmentation/aging and reduced in vivo skin aging signs, with a good safety profile after 90 days of daily use.
- 12 February 2022
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 21 (10) , 4462-4469
Efficacy of a topical serum containing L‐ascorbic acid, neohesperidin, pycnogenol, tocopherol, and hyaluronic acid in relation to skin aging signs
Background: Skin aging is a process regulated by chronological aging and amplified by exposome factors including chronic UV exposure and pollution, which both induce reactive oxygen species. Topical antioxidants have the potential to counteract this process and to improve skin aging signs, including wrinkles and hyperpigmentation.Objective: To evaluate the efficacy of a topical antioxidant serum containing 15% L‐ascorbic acid, neohesperidin, Pinus pinaster bark, tocopherol, and hyaluronic acid (HA) ex vivo on air pollution‐induced pigmentation and gene expression, as well as in vivo on skin aging signs in Brazilian volunteers, after 90 days of use.Methods: Ex vivo human skin samples were repetitively exposed to Diesel Exhaust Particles (DEP) and subsequently analyzed for changes in pigmentation and gene expression. Clinical efficacy was evaluated in 40 healthy adult females with phototype II to IV and visible photoaging signs, including facial hyperpigmentation, through dermatological evaluation and instrumental analysis including Reflectance Confocal Microscopy.Results: Ex vivo, the topical antioxidant serum significantly reduced DEP‐induced skin pigmentation and expression of proinflammatory genes. A significant improvement of skin aging signs was observed after 90 days. Local tolerance was good.Conclusion: The tested serum is effective in protecting human skin ex vivo against air pollution‐induced skin pigmentation/aging and reduced in vivo skin aging signs, with a good safety profile after 90 days of daily use.